Tegavivint

Star1

DB17109InvestigationalSmall molecule

Tegavivint: Overview.

Formula / weight: C₂₈H₃₆N₄O₆S₂ · 588.74 g/mol (avg)
Code names: BC-2059

Resolves to

Compound

UNII18AP231HUPCAS1227637-23-1

Structure

InChIKeyGAPRVZKWPDRAJA-TVRZPQSBSA-NSMILESC[C@H]1C[C@@H](C)CN(C1)S(=O)(=O)C1=CC=C2C(=C1)C(=NO)C1=CC(=CC=C1C2=NO)S(=O)(=O)N1C[C@@H](C)C[C@@H](C)C1

Targets

O60907TBL1XP35222CTNNB1

What you can answer from here — as of November 04, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

8Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Tegavivint, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account